Bragar Eagel & Squire, P.C. Reminds Investors of Class Actions Against Neogen, Alto, RxSight, and Replimune and Encourages Investors to Contact the FirmNEW YORK, July 28, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Neogen Corporation (
NASDAQ:NEOG), Alto Neuroscience, Inc. (
NYSE:ANRO), RxSight, Inc. (
NASDAQ:RXST), and Replimune Group, Inc. (
NASDAQ:REPL). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in RxSight, Inc. of Class Action Lawsuit and Upcoming Deadlines - RXSTNEW YORK, July 28, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against RxSight, Inc. (“RxSight” or the “Company”)(
NASDAQ: RXST). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
RXST INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that RxSight, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
The law firm of Robbins Geller Rudman & Dowd LLP announces that the RxSight class action lawsuit – captioned Makaveev v. RxSight, Inc., No. 25-cv-01596 (C.D. Cal.) – seeks to represent purchasers or acquirers of RxSight, Inc. (
NASDAQ: RXST) securities and charges RxSight as well as certain of RxSight’s executives with violations of the Securities Exchange Act of 1934.
Levi & Korsinsky Notifies Shareholders of RxSight, Inc.(RXST) of a Class Action Lawsuit and an Upcoming DeadlineSearch for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Levi & Korsinsky Notifies Shareholders of RxSight, Inc.(RXST) of a Class Action Lawsuit and an Upcoming DeadlineNEW YORK - July 28, 2025 ( NEWMEDIAWIRE ) - Levi & Korsinsky, LLP notifies investors in RxSight, Inc. (
NASDAQ: RXST) of a class action securities lawsuit.
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against RxSight, Inc. (NASDAQ: RXST)NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the securities of RxSight, Inc. (“RxSight” or the “Company”) (
NASDAQ: RXST) between November 7, 2024 and July 8, 2025, inclusive.
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of RxSight
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against RxSight, Inc. (“RxSight” or the “Company”) (
NASDAQ: RXST) and reminds investors of the September 22, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
Deadline Approaching: RxSight, Inc. (RXST) Investors Who Lost Money Urged to Contact Law Offices of Howard G. Smith
Law Offices of Howard G. Smith reminds investors of the upcoming September 22, 2025 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased RxSight, Inc. (“RxSight” or the “Company”) (
NASDAQ: RXST) securities between November 7, 2024 and July 8, 2025, inclusive (the “Class Period”).
RxSight, Inc. to Report Second Quarter 2025 Financial Results on August 7, 2025ALISO VIEJO, Calif., July 24, 2025 (GLOBE NEWSWIRE) -- (
NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, will report financial results for the second quarter of 2025 after the market close on Thursday, August 7, 2025. The company’s management will discuss the results during a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
Deadline Alert: RxSight, Inc. (RXST) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit
Glancy Prongay & Murray LLP reminds investors of the upcoming September 22, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired RxSight, Inc. (“RxSight” or the “Company”) (
NASDAQ: RXST) securities between November 7, 2024 and July 8, 2025, inclusive (the “Class Period”).
Berger Montague PC Investigates Potential Securities Law Violations by RxSight, Inc. (NASDAQ: RXST) Following Class Action FilingPHILADELPHIA, July 24, 2025 (GLOBE NEWSWIRE) -- Berger Montague PC, a nationally recognized securities litigation law firm, is investigating potential securities law violations involving RxSight, Inc. (“RxSight” or the “Company”) (
NASDAQ: RXST). A class action lawsuit was recently filed on behalf of investors who acquired RxSight securities between November 7, 2024 and July 8, 2025 (the “Class Period”).
RXST INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that RxSight, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
The law firm of Robbins Geller Rudman & Dowd LLP announces that the RxSight class action lawsuit – captioned Makaveev v. RxSight, Inc., No. 25-cv-01596 (C.D. Cal.) – seeks to represent purchasers or acquirers of RxSight, Inc. (
NASDAQ: RXST) securities and charges certain of RxSight’s executives with violations of the Securities Exchange Act of 1934.
RXSIGHT ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against RxSight, Inc. and Encourages Investors to Contact the FirmBragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In RxSight (RXST) To Contact Him Directly To Discuss Their Options
RXST Investors Have Opportunity to Lead RxSight, Inc. Securities Fraud Lawsuit with the Schall Law Firm
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against RxSight, Inc. (“RxSight” or “the Company”) (
NASDAQ: RXST) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
RXST LEGAL UPDATE: RxSight, Inc. Sued for Fraud Amid Declining LAL Utilization -- Investors with Losses are Notified to Contact BFA Law before September 22 Class Action Deadline
Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against RxSight, Inc. (
NASDAQ: RXST) and certain of the Company’s senior executives for potential violations of the federal securities laws.
Law Offices of Frank R. Cruz Encourages RxSight, Inc. (RXST) Investors To Inquire About Securities Fraud Class Action
The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of investors who purchased RxSight, Inc. (“RxSight” or the “Company”) (
NASDAQ: RXST) securities between November 7, 2024 and July 8, 2025, inclusive (the “Class Period”). RxSight investors have until September 22, 2025 to file a lead plaintiff motion.
Law Offices of Howard G. Smith Encourages RxSight, Inc. (RXST) Investors To Inquire About Securities Fraud Class Action
Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased RxSight, Inc. (“RxSight” or the “Company”) (
NASDAQ: RXST) securities between November 7, 2024 and July 8, 2025, inclusive (the “Class Period”). RxSight investors have until September 22, 2025 to file a lead plaintiff motion.
Rosen Law Firm Urges RxSight, Inc. (NASDAQ: RXST) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights
Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action on behalf of purchasers of securities of RxSight, Inc. (
NASDAQ: RXST) between November 7, 2024 and July 8, 2025. RxSight describes itself as a “commercial-stage medical technology company, engaged in the research and development, manufacture, and sale of light adjustable intraocular lenses.”
RXSIGHT, INC. (NASDAQ: RXST) INVESTOR ALERT Investors With Large Losses in RxSight Inc. Should Contact Bernstein Liebhard LLP To Discuss Their RightsNEW YORK, July 23, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the securities of RxSight, Inc. (“RxSight” or the “Company”) (
NASDAQ: RXST) between November 7, 2024 and July 8, 2025, inclusive.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of RxSight, Inc. - RXSTNEW YORK, July 23, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of (“RxSight” or the “Company”) (
NASDAQ: RXST). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
